Premium
OptimizeRx Corporation (OPRX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Ms. Theresa GrecoChief Commercial Officer | -1,79k | 9,34k | Sale to Issuer | 5,21 | 32,60k | -5,21% |
| 2026-05-15 | Mr. Stephen L. SilvestroCEO & Director | -5,22k | 27,19k | Sale to Issuer | 5,21 | 110,76k | -4,50% |
| 2026-02-11 | Ms. Marion K Odence-FordChief Legal & Administrative Officer | 2,61k | 0,00 | Derivative Exercise and Retained Stock | - | 48,71k | 5,67% |
| 2026-02-11 | Ms. Marion K Odence-FordChief Legal & Administrative Officer | -1,39k | 12,79k | Derivative Exercise and Sale | 9,23 | 48,71k | - |
| 2025-12-23 | Mr. Stephen L. SilvestroCEO & Director | -3,36k | 42,82k | Sale to Issuer | 12,74 | 100,33k | -3,24% |
| 2025-12-23 | Ms. Theresa GrecoChief Commercial Officer | -1,42k | 18,09k | Sale to Issuer | 12,74 | 31,24k | -4,35% |
| 2025-12-23 | Ms. Marion K Odence-FordChief Legal & Administrative Officer | -4,05k | 51,61k | Sale to Issuer | 12,74 | 46,09k | -8,08% |
| 2025-12-23 | Mr. Edward StelmakhChief Financial & Strategic Officer | -3,66k | 46,60k | Sale to Issuer | 12,74 | 79,94k | -4,38% |
| 2025-12-23 | Dr. Doug BeschChief Product Officer & CTO | -4,08k | 51,97k | Sale to Issuer | 12,74 | 23,65k | -14,71% |
| 2025-12-19 | Mr. Edward StelmakhChief Financial & Strategic Officer | 3,85k | 0,00 | Derivative Exercise and Retained Stock | - | 69,80k | 5,84% |
| 2025-12-19 | Mr. Edward StelmakhChief Financial & Strategic Officer | -1,39k | 18,75k | Derivative Exercise and Sale | 13,51 | 69,80k | - |
| 2025-12-19 | Mr. Stephen L. SilvestroCEO & Director | 4,95k | 0,00 | Derivative Exercise and Retained Stock | - | 89,89k | 5,83% |
| 2025-12-19 | Mr. Stephen L. SilvestroCEO & Director | -1,59k | 21,53k | Derivative Exercise and Sale | 13,51 | 89,89k | - |
| 2025-12-19 | Ms. Marion K Odence-FordChief Legal & Administrative Officer | 2,78k | 0,00 | Derivative Exercise and Retained Stock | - | 36,34k | 8,27% |
| 2025-12-19 | Ms. Marion K Odence-FordChief Legal & Administrative Officer | -1,15k | 15,58k | Derivative Exercise and Sale | 13,51 | 36,34k | - |
| 2025-12-19 | Mr. Brendan MerrellCOO | -289,00 | 3,90k | Sale to Issuer | 13,51 | 9,96k | -2,82% |
| 2025-12-19 | Mr. Andrew Jacob D'SilvaChief Business Officer | -703,00 | 9,50k | Sale to Issuer | 13,51 | 21,19k | -3,21% |
| 2025-12-19 | Dr. Doug BeschChief Product Officer & CTO | 1,38k | 0,00 | Derivative Exercise and Retained Stock | - | 13,92k | 11,03% |
| 2025-12-19 | Dr. Doug BeschChief Product Officer & CTO | -581,00 | 7,85k | Derivative Exercise and Sale | 13,51 | 13,92k | - |
| 2025-12-11 | Mr. Brendan MerrellCOO | -712,00 | 9,99k | Sale to Issuer | 14,03 | 9,27k | -7,14% |
| 2025-12-11 | Mr. Andrew Jacob D'SilvaChief Business Officer | -868,00 | 12,18k | Sale to Issuer | 14,03 | 19,93k | -4,17% |
| 2025-10-03 | Mr. Brendan MerrellCOO | -483,00 | 9,06k | Sale to Issuer | 18,75 | 7,55k | -6,01% |
| 2025-10-01 | Mr. Andrew Jacob D'SilvaChief Business Officer | -1,21k | 22,75k | Sale to Issuer | 18,75 - 18,98 | 18,37k | -6,17% |
| 2025-11-01 | Ms. Theresa GrecoChief Commercial Officer | -1,69k | 34,69k | Sale to Issuer | 20,49 | 27,48k | -5,80% |
| 2025-10-03 | Ms. Marion K Odence-FordChief Legal & Administrative Officer | 4,70k | 0,00 | Derivative Exercise and Retained Stock | - | 33,57k | 16,27% |
| 2025-10-03 | Ms. Marion K Odence-FordChief Legal & Administrative Officer | -1,95k | 36,60k | Derivative Exercise and Sale | 18,75 | 33,57k | - |
| 2025-10-03 | Mr. Edward StelmakhChief Financial & Strategic Officer | 12,22k | 0,00 | Derivative Exercise and Retained Stock | - | 65,95k | 22,74% |
| 2025-10-03 | Mr. Edward StelmakhChief Financial & Strategic Officer | -4,41k | 82,61k | Derivative Exercise and Sale | 18,75 | 65,95k | - |
| 2025-10-03 | Mr. Stephen L. SilvestroCEO & Director | 5,03k | 0,00 | Derivative Exercise and Retained Stock | - | 84,94k | 6,29% |
| 2025-10-03 | Mr. Stephen L. SilvestroCEO & Director | -1,62k | 30,38k | Derivative Exercise and Sale | 18,75 | 84,94k | - |
| 2025-10-03 | Dr. Doug BeschChief Product Officer & CTO | -983,00 | 18,43k | Derivative Exercise and Sale | 18,75 | 12,54k | - |
| 2025-10-03 | Dr. Doug BeschChief Product Officer & CTO | 2,34k | 0,00 | Derivative Exercise and Retained Stock | - | 12,54k | 22,97% |
| 2025-08-28 | Mr. Patrick D. SpanglerIndependent Director | -11,12k | 194,49k | Vente | 17,49 | 34,35k | -24,46% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
